XML 21 R6.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit​
Common Stock Including Additional Paid in Capital
Beginning balance (in shares) at Dec. 31, 2023   181,364,180        
Beginning balance at Dec. 31, 2023 $ 3,145,305 $ 1,815 $ 6,611,237 $ 1,428 $ (3,469,175)  
Increase (Decrease) in Stockholders' Equity            
Exercise of common stock options (in shares)   71,537        
Stock Issued During Period, Value, Stock Options Exercised   $ 1 (1,409)     $ (1,408)
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures   1,792,087        
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures (44) $ 17 (61)      
Issuance of common stock to fund the Company's 401(k) match 40,550 $ 6 40,544      
Employee Benefits and Share-Based Compensation 60,370   60,370      
Net loss (110,228)       (110,228)  
Other comprehensive income (loss) (1,927)     (1,927)    
Ending balance (in shares) at Mar. 31, 2024   183,845,188        
Ending balance at Mar. 31, 2024 3,132,618 $ 1,839 6,710,681 (499) (3,579,403)  
Beginning balance (in shares) at Dec. 31, 2023   181,364,180        
Beginning balance at Dec. 31, 2023 3,145,305 $ 1,815 6,611,237 1,428 (3,469,175)  
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock to fund the Company's 401(k) match (in shares)   617,384        
Issuance of common stock to fund the Company's 401(k) match 40,550          
Net loss (126,036)          
Ending balance (in shares) at Jun. 30, 2024   184,668,188        
Ending balance at Jun. 30, 2024 3,192,362 $ 1,848 6,786,668 (943) (3,595,211)  
Beginning balance (in shares) at Mar. 31, 2024   183,845,188        
Beginning balance at Mar. 31, 2024 3,132,618 $ 1,839 6,710,681 (499) (3,579,403)  
Increase (Decrease) in Stockholders' Equity            
Exercise of common stock options (in shares)   8,184        
Stock Issued During Period, Value, Stock Options Exercised   $ 1 42     43
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures   210,590        
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures (4) $ 2 (6)      
Employee Benefits and Share-Based Compensation $ 56,555   56,555      
Stock Issued During Period, Shares, Employee Stock Purchase Plans 604,226          
Stock Issued During Period, Value, Employee Stock Purchase Plan $ 19,402 $ 6 19,396      
Net loss (15,808)       (15,808)  
Other comprehensive income (loss) (444)     (444)    
Ending balance (in shares) at Jun. 30, 2024   184,668,188        
Ending balance at Jun. 30, 2024 $ 3,192,362 $ 1,848 6,786,668 (943) (3,595,211)  
Beginning balance (in shares) at Dec. 31, 2024 185,616,438 185,616,438        
Beginning balance at Dec. 31, 2024 $ 2,402,249 $ 1,857 6,899,368 (944) (4,498,032)  
Increase (Decrease) in Stockholders' Equity            
Exercise of common stock options (in shares)   35,349        
Stock Issued During Period, Value, Stock Options Exercised   $ 0 (422)     (422)
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures   2,149,825        
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures (4,223) $ 22 (4,245)      
Issuance of common stock to fund the Company's 401(k) match 43,943 $ 8 43,935      
Employee Benefits and Share-Based Compensation 54,618   54,618      
Net loss (101,215)       (101,215)  
Other comprehensive income (loss) 1,957     1,957    
Ending balance (in shares) at Mar. 31, 2025   188,594,669        
Ending balance at Mar. 31, 2025 $ 2,396,907 $ 1,887 6,993,254 1,013 (4,599,247)  
Beginning balance (in shares) at Dec. 31, 2024 185,616,438 185,616,438        
Beginning balance at Dec. 31, 2024 $ 2,402,249 $ 1,857 6,899,368 (944) (4,498,032)  
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock to fund the Company's 401(k) match (in shares)   793,057        
Issuance of common stock to fund the Company's 401(k) match 43,943          
Net loss $ (102,400)          
Ending balance (in shares) at Jun. 30, 2025 189,220,577 189,220,577        
Ending balance at Jun. 30, 2025 $ 2,469,414 $ 1,893 7,064,867 3,086 (4,600,432)  
Beginning balance (in shares) at Mar. 31, 2025   188,594,669        
Beginning balance at Mar. 31, 2025 2,396,907 $ 1,887 6,993,254 1,013 (4,599,247)  
Increase (Decrease) in Stockholders' Equity            
Exercise of common stock options (in shares)   8,223        
Stock Issued During Period, Value, Stock Options Exercised   $ 0 293     $ 293
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures   198,615        
Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures (490) $ 2 (492)      
Employee Benefits and Share-Based Compensation 55,783   55,783      
Stock Issued During Period, Shares, Employee Stock Purchase Plans   419,070        
Stock Issued During Period, Value, Employee Stock Purchase Plan 16,033 $ 4 16,029      
Net loss (1,185)       (1,185)  
Other comprehensive income (loss) $ 2,073     2,073    
Ending balance (in shares) at Jun. 30, 2025 189,220,577 189,220,577        
Ending balance at Jun. 30, 2025 $ 2,469,414 $ 1,893 $ 7,064,867 $ 3,086 $ (4,600,432)